SPECTRANETICS QUICK-CROSS EXTREME SUPPORT CATHETERS

K082561 · Spectranetics Corp. · DQY · Dec 10, 2008 · Cardiovascular

Device Facts

• Record ID: K082561
• Device Name: SPECTRANETICS QUICK-CROSS EXTREME SUPPORT CATHETERS
• Applicant: Spectranetics Corp.
• Product Code: DQY · Cardiovascular
• Decision Date: Dec 10, 2008
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.1250
• Device Class: Class 2

Intended Use

Quick-Cross® Extreme Support Catheters are intended to guide and support a guidewire during access of the vasculature, allow for wire exchanges and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.

Device Story

Support catheter used by cardiovascular interventionists to navigate vasculature; provides conduit for guidewire support, wire exchange, and delivery of saline or diagnostic contrast agents. Device features stainless steel braided shaft for torque response and support; tapered tip; hydrophilic coating for lubricity; three radiopaque markers for visualization. Operated by physician in clinical setting. Output is physical support for guidewire and delivery path for fluids. Benefits include facilitated vascular access and procedural efficiency during interventional cardiovascular procedures.

Clinical Evidence

Bench testing only. No clinical data presented. Testing included physical dimensions, infusion rates, burst pressure, and biocompatibility validation per ISO 10993-1.

Technological Characteristics

Stainless steel braided shaft; tapered tip; hydrophilic coating; 4Fr size; 0.059" OD; 65-150 cm lengths; 0.035" guidewire compatibility; 500 psi max pressure. Sterilized via Ethylene Oxide per ANSI/AAMI/ISO 11135:1994. Complies with ISO 1055-1.

Indications for Use

Indicated for use in patients requiring vascular access for guidewire support, wire exchange, or delivery of saline/contrast agents. No specific age or gender restrictions provided.

Regulatory Classification

Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

Predicate Devices

• Quick-Cross® Support2 Catheters (K991059, K022138, K033678, and K072750)
• Terumo RadiFocus Optitorque (K992051)

Submission Summary (Full Text)

{0}------------------------------------------------

# 510(k) Summary

# SUBMITTER INFORMATION

DEC 1 0 2008

KORZS

page 1 of 2

- A. Company Name: Spectranetics Corporation, Inc.
- B. Company Address: 96 Talamine Court

Colorado Springs, Colorado 80907

- C. Company Phone: [phone]
- D. Company Facsimile: 719-447-2040
- E. Contact Person: Michael K. Handley
- Vice President, Global Regulatory Affairs & Compliance

# DEVICE IDENTIFICATION

- A. Device Trade Name: Spectranetics Quick-Cross Extreme Support Catheters
- B. Device Common Name: Support Catheters
- C. Classification Name: Catheter, Percutaneous
- D. Device Class: Class II (per 21 CFR 870.1330)
- E. Device Code: DQY

# CLAIMED EQUIVALENCE

Quick-Cross® Support2 Catheters (K991059, K022138, K033678, and K072750)

4Fr Terumo RadiFocus Optitorque (K992051)

# DEVICE DESCRIPTION

# Specifications:

| Model<br>(Ref.) | Size | Max. (OD)<br>Outer<br>Diameter | Working<br>Length | Guide Wire<br>Compatability | *Max<br>Pressure<br>psi (kPa) | Tip Shape |
|-----------------|------|--------------------------------|-------------------|-----------------------------|-------------------------------|-----------|
| 518-076 | 4 Fr | 0.059" / 1.50 mm | 65 cm | .035" | 500 (3447) | Straight |
| 518-078 | 4 Fr | 0.059" / 1.50 mm | 90 cm | .035" | 500 (3447) | Straight |
| 518-080 | 4 Fr | 0.059" / 1.50 mm | 135 cm | .035" | 500 (3447) | Straight |
| 518-082 | 4 Fr | 0.059" / 1.50 mm | 150 cm | .035" | 500 (3447) | Straight |
| 518-077 | 4 Fr | 0.059" / 1.50 mm | 65 cm | .035" | 500 (3447) | Angled |
| 518-079 | 4 Fr | 0.059" / 1.50 mm | 90 cm | .035" | 500 (3447) | Angled |
| 518-081 | 4 Fr | 0.059" / 1.50 mm | 135 cm | .035" | 500 (3447) | Angled |
| 518-083 | 4 Fr | 0.059" / 1.50 mm | 150 cm | .035" | 500 (3447) | Angled |

* 75/25 Optiray 320 Contrast Sterile Saline

All models have 3 radiopaque markers spaced equally along the distal shaft to aid in estimating geometry within the vascular system. The most distal radiopaque marker is positioned within 3 mm of the distal catheter tip. A standard female luer is placed on the proximal end of each model. The catheter is coated with a lubricious, hydrophilic coating, Predicate devices of this type with similar intended uses have been classified into Class II. The support catheters are single-use and provided in sterile packaging.

{1}------------------------------------------------

### INTENDED USE

Quick-Cross® Extreme Support Catheters are intended to guide and support a guidewire during access of the vasculature, allow for wire exchanges and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.

### IDENTIFICATION OF PREDICATE DEVICES

Spectranetics Quick-Cross Extreme Support Catheters are equivalent to the Terumo 4Fr Radifocus Optitorque Angiographic Catheter (K992051), marketed as the 5Fr Radifocus Glidecath, with regard to materials, basic design principles, construction, specifications, intended use and performance. It is also equivalent to the Spectranetics Quick-Cross Support Catheter Both are examples of a support catheter for guide wires, a common and familiar tool of cardiovascular interventionist.

#### COMPARISON TO PREDICATE DEVICES

Comparative laboratory testing was conducted to assess physical dimensions, infusion rates and burst pressure. Test results show that the Spectranetics Quick-Cross Extreme Support Catheters are equivalent to the predicate devices with regard to safety, effectiveness, indication and performance.

#### BIOCOMPATIBILITY, STERILIZATION, PACKAGING, AND BENCH TESTING

Quick-Cross Extreme Support Catheters are built from the same components and materials of construction as the predicate devices, already-marketed products. Biocompatibility of the finished Quick-Cross Extreme Support Catheters utilizing identical component materials have been confirmed in conformance with ISO 10993-1:2003, Biological Evaluation of Medical Devices. Device integrity and functionality were qualified and/or validated using samples produced under routine manufacturing conditions. An internal company protocol was prepared and executed in conformance with ANSI/AAMI/ISO 11135:1994, Medical Devices -Validation and Routine Control of Ethylene Oxide Sterilization. All Quick-Cross Extreme Support Catheters models meet or exceed both Spectranetics in-house requirements, and requirements listed in ISO 1055-1, Sterile, Single-use Intravascular Catheters - Part 1: General Requirements. Package integrity was initially validated in conjunction with sterilization studies.

#### TECHNILOGICAL CHARACTERISTICS

The Spectranetics Quick-Cross Extreme Support Catheters have the same technical characteristics as the Terumo 4Fr Radifocus Optitorque (GlideCath) and the Quick-Cross Support Catheters, the predicate devices. Both devices feature a stainless steel braided shaft for aided support and torque response and a tapered tip. All support catheters have a 0.066 inch diameter with the capacity to accommodate up to 0.035" diameter quidewires depending on the model.

#### CONCLUSION

The Spectranetics Quick-Cross Extreme Catheters are substantially equivalent to the predicate devices.

{2}------------------------------------------------

#### DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. The eagle is black, and the text is also black. The background is white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC 1 0 2008

Spectranetics Corporation, Inc. c/o Mr. Michael K. Handley Vice President Global Regulatory Affairs & Compliance 9965 Federal Drive Colorado Springs, CO 80921

Re: K082561

Spectranetics Quick-Cross® Extreme Support Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DQY Dated: November 18, 2008 Received: November 19, 2008

Dear Mr. Handley:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

{3}------------------------------------------------

# Page 2 - Mr. Michael K. Handley

CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Bram D. Zuckerman, M.D.

Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the word "Spectranetics" in a stylized, bold, sans-serif font. The text is white against a black background, creating a high contrast. The font appears slightly distressed, giving it a vintage or textured look. The word is presented in a single line, with each letter clearly legible.

.spectranetlcs.com

510(k) #: K082561

# Statement of Indication for Use

Device Name: Spectranetics Quick-Cross® Extreme Support Catheters

# Indications for Use

Quick-Cross® Extreme Support Catheters are intended to guide and support a guide wire during access of the vasculature, allow for wire exchanges and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.

Prescription Use XXXX

AND/OR

Over-The-Counter Use

(Part 21 CFR 801 Subpart D)

(21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division/Sign-Off)
Division of Cardiovascular, Devices
510(k) Number K082561